Cultivars of Apple Fruits That Are Not Marketed with Potential for Anthocyanin Production

Vanisree Mulabagal, Steven Van Nocker, David L. Dewitt§ and Muraleedharan G. Nair*
Bioactive Natural Products and Phytoceuticals, Department of Horticulture and National Food Safety and Toxicology Center, Department of Horticulture, and Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824
J. Agric. Food Chem., 2007, 55 (20), pp 8165–8169
DOI: 10.1021/jf0718300
Publication Date (Web): September 7, 2007
Copyright © 2007 American Chemical Society

Department of Horticulture and National Food Safety and Toxicology Center.

,

Department of Horticulture.

,
§

Department of Biochemistry and Molecular Biology.

,
* Author to whom correspondence should be addressed. Fax: (517) 432-2310. E-mail: nairm@msu.edu.

Abstract

The red coloration of apple skin is mainly due to anthocyanins that are reported to possess health benefits. The aim of the present study was to determine the anthocyanin content in three underutilized Malus pumila Mill cultivars, Cranberry, Kerr, and Niedzwetzkyana, and confirm their anti-inflammatory and antioxidant activities. Our analysis revealed that the three cultivars studied contained primarily cyanidin-3- O-glucosyl rutinoside ( 1) at >99%. The anthocyanin was purified by C-18 medium pressure liquid chromatography and characterized by NMR spectral methods. The quantification of anthocyanins in M. pumila cultivars revealed that Cranberry, Kerr, and Niedzwetzkyana contained 1.12, 0.55, and 0.36 mg/g of fresh weight of 1, respectively. The lipid peroxidation (LPO) and cyclooxygenase enzyme (COX) inhibitory activities of 1 in water were compared with the activities of cyanidin-3- O-rutinoside ( 2) and cyanidin-3- O-glucoside ( 3) found in cherries and berries. There is a significant increase in LPO and COX enzyme-inhibitory activities of anthocyanin when tested in water compared to using dimethylsulfoxide as the carrier. The LPO inhibition of anthocyanins 1, 2, and 3 were 53.3, 68.3, and 87.9, respectively, at a 0.25 µM concentration. They inhibited the COX-1 enzyme by 42.7, 45.2, and 50.4 and COX-2 by 52.7, 61.5, and 68.5, respectively, at 5 µM. The LPO inhibitory values for commercial standards, BHA, BHT, and TBHQ, were 85, 89, and 94%, respectively at 1 µM. Similarly, positive controls aspirin, celecoxib, and robecoxib inhibited COX-1 and -2 enzymes by 68.6, 40.7, and 0% and 26.6, 72.2, and 92.4%, respectively, at 60, 26, and 32 nM.

Tools

History

  • Published In Issue October 03, 2007
  • Article ASAPSeptember 07, 2007
  • Received: June 20, 2007
    Accepted: August 08, 2007
    Revised: August 07, 2007

Recommend & Share

Related Content

Other ACS content by these authors: